Home › NDC Lookup › RxCUI directory › RxCUI 865573

24 HR glipizide 5 MG Extended Release Oral Tablet [Glucotrol] — RxCUI 865573

RxNorm drug concept · Semantic branded drug
RxCUI 865573 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI865573
Official name24 HR glipizide 5 MG Extended Release Oral Tablet [Glucotrol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Glucotrol XL 5 MG Extended Release Oral Tablet; Glucotrol XL 5 MG 24HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glipizide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Glipizide helps lower your blood sugar by prompting your pancreas to release more insulin — especially after meals. It's used in type 2 diabetes alongside diet and exercise, not as...
  • What exactly is glipizide supposed to do for my diabetes?
  • The regular tablet works relatively quickly and is usually taken about 30 minutes before a meal. The extended-release tablet (including the brand Glucotrol XL) releases the medicin...
  • What's the difference between the regular tablet and the extended-release tablet?
📖 Read our full Glipizide guide →

🕸️ Concept Web — How 24 HR glipizide 5 MG Extended Release Oral Table... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR glipizide 5 MG Extended Release Oral Tablet [Glucotrol] RxCUI 865573

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glipizide 4821
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Glucotrol 203680
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glipizide Extended Release Oral Tablet 700835
    • Glipizide Oral Product 1165207
    • Glipizide Pill 1165208
    • Glipizide Extended Release Oral Tablet [Glucotrol] 865567
    • Glucotrol Oral Product 1171246
    • Glucotrol Pill 1171247
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Glipizide 5 MG [Glucotrol] SBDC · 566718
  • Glipizide Extended Release Oral Tablet [Glucotrol] SBDF · 865567
  • Glucotrol Oral Product SBDG · 1171246
  • Glucotrol Pill SBDG · 1171247
  • Glucotrol BN · 203680

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 865573 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00049-0174-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0174-02) Glucotrol XL Roerig 2013-05-09
00049-0174-03 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0174-03) Glucotrol XL Roerig 2013-05-09
00049-0178-08 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0178-08) Glucotrol XL Roerig 2013-05-09
Observed labelers: Roerig (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.